WHO ICTRP trial
Cell saver autologous blood transfusion versus allogenic transfusion in…
JPRN-jRCT1052240102 · Japan Primary Registries Network (JPRN) · Not Recruiting
Key facts
| Trial ID | JPRN-jRCT1052240102 |
|---|---|
| Public title | Cell saver autologous blood transfusion versus allogenic transfusion in cardiovascular surgery |
| Scientific title | Cell saver autologous blood transfusion versus allogenic transfusion in cardiovascular surgery: a randomized controlled non-inferiority trial. |
| Primary sponsor | Tsukinaga Akito |
| Registry | Japan Primary Registries Network (JPRN) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Conditions | Patients undergoing cardiovascular surgery Cardiovascular Surgery;Cardiovascular Surgical Procedures |
| Interventions | Consent will be obtained and provisionally registered before the day of surgery. Final registration/allocation will be conducted during CPB, and the study product will be transfused from the time of withdrawal from the CPB (when protamine… |
| Registration date | Jan 8, 2024 |
| Target size | 142 |
| Registry page | jrct.niph.go.jp |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: